Secreted and transmembrane proteins are critical to the cell-cell interactions governing normal development and carcinogenesis. To facilitate the identification of such molecules, we have developed a novel signal sequence trap that uses human placental alkaline phosphatase as a reporter. Libraries from mouse prostate and human prostatic carcinoma were constructed to test the PST (peptide signal trap) system, resulting in the identification of several secreted and transmembrane proteins.
Interactions between cells and their environment, whether it be other cells or the extracellular matrix, are crucial for regulating cellular growth and differentiation. The key molecules responsible for these communications are secreted and transmembrane proteins. Therefore, identification of such molecules can uncover growth control pathways important in normal development and/or carcinogenesis.
The development of signal sequence traps has facilitated the isolation of secreted and transmembrane factors (1) . These signal peptide traps are based on the observation that the majority of secreted and type I integral membrane proteins have N-terminal signal peptides that target localization to the extracellular compartment. A signal peptide consists of ∼20 amino acids, containing a basic N-terminus, a hydrophobic center, and a polar C-terminus. After its translocation into the endoplasmic reticulum, the signal peptide is cleaved from the mature protein (2) . Signal peptides can be heterologously fused to other proteins and function to bring the foreign proteins to the cell surface (3) . This ability to direct subcellular localization of chimeric proteins can be harnessed to clone secreted and transmembrane proteins. By fusing a cDNA library upstream of a reporter gene and assaying for the reporter's presence on the cell surface, one can identify cDNAs encoding functional signal peptides. Such a signal peptide trap facilitates the isolation of growth factors, their receptors, matrix-binding proteins and other growth regulatory molecules.
Several useful signal sequence traps have been developed (1, (4) (5) (6) . Although they all enrich for secreted and transmembrane proteins, they use time-consuming and equipment-dependent immunostaining and flow cytometry techniques to recognize their reporters. To overcome these complications, we have designed a unique signal peptide trap which uses the transmembrane Figure 1 . PST vector. The pcDNAI (Invitrogen) plasmid was modified by replacing the polylinker from HindIII to XhoI with a 2.1 kb PLAP cDNA insert, thus destroying all sites, inclusive. The PLAP cDNA lacks its translational start and signal sequence, and therefore begins with the codon for the first amino acid of mature PLAP (DDBJ/EMBL/GenBank accession no. M13077, nucleotide 105). A new polylinker inserted between the CMV promoter and the signalless PLAP creates ClaI, EcoRI, XhoI, HindIII and SalI sites, in that order, allowing our EcoRI/HindIII cDNA library to be cloned upstream of PLAP. The pcDNAI SV40 intron/polyadenylation site resides 3′ to PLAP.
human placental alkaline phosphatase gene (PLAP; DDBJ/ EMBL/GenBank accession no. M13077) as a reporter (Fig. 1) . Our peptide signal trap (PST) vector contains the cytomegalovirus immediate-early gene (CMV) promoter positioned upstream of the PLAP gene lacking its endogenous signal sequence, including the translation-initiating ATG. A short polylinker immediately after the CMV promoter allows for cloning of cDNA inserts. Only cDNAs encoding a start codon and functional signal peptide fused in-frame to PLAP will direct export of the chimeric protein to the cell surface. This requirement eliminates some false positives which can arise from internal stretches of highly hydrophobic amino acids.
PLAP is an ideal reporter protein for the signal peptide trap system for several reasons. Most importantly, it functions only when brought to the cell surface; cytoplasmic alkaline phosphatase is inert (7) . Also, an easy colorimetric assay can be performed, with commercially available indicator substrates, to identify cells containing functional PLAP. Lastly, PLAP is very thermal-stable, as opposed to the majority of other alkaline phosphatases which are heat-labile. Therefore, a brief heat-inactivation step eliminates background activity from cellular alkaline phosphatases (8) .
To test our PST system, we constructed two control plasmids, PST-LIF and PST-ld. PST-LIF contains 390 bp of leukemia inhibitory factor's cDNA, including its translational start and signal sequence, fused in-frame to PLAP. LIF is normally secreted (9) , and therefore served as a positive control for our signal peptide trap. As a negative control, we cloned the first 465 bp of formin's isoform IV's coding region into PST, resulting in PST-ld. Since formin is normally not secreted (10), the PST-ld product should not allow for PLAP activity. The original pPLAP vector, PST-LIF, and PST-ld all produced PLAP protein when transfected into COS-7 cells (American Type Culture Collection; data not shown). We tested for PLAP activity by fixing the transfected cells in 4% paraformaldehyde, heat inactivating endogenous alkaline phosphatase activity, and staining with 4-nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP; Boehringer Mannheim). As expected, cells transfected with pPLAP or PST-LIF displayed purple staining, while cells transfected with PST or PST-ld lacked coloration (Fig. 2) . To test the sensitivity of this assay, we transfected cells with different ratios of pPLAP:PST. Positive cells were still easily detected at a 1:10 000 ratio (data not shown).
Since our controls indicated that the PST system could indeed distinguish between signal peptide containing proteins and cytoplasmic proteins, we decided to test its ability to enrich for secreted and transmembrane proteins of a given tissue. To this end, we constructed an adult mouse prostate cDNA library in the PST vector. Our cDNA was synthesized using a directional random priming strategy (OrientExpress, Novagen). When the cDNA, synthesized from the directional primer (5′-dTTN 6 -3′), was ligated to EcoRI linkers (5′-GCTTGAATTCAAGC-3′), a HindIII site (5′-AAGCTT-3′) was created at the 3′ end of the cDNA, thus allowing EcoRI/HindIII directional cloning. This method bypasses the problems in the cDNA construction protocols of other signal sequence traps, namely the difficulties with efficiency and sequencing associated with deoxycytosine tailing, and the mutations caused by polymerase chain reaction (PCR) (1, 4, 5) . We size-selected, by gel electrophoresis, for cDNA inserts of 300-500 bp, since this size range has fewer stop codons than longer cDNAs and fewer artifacts than shorter ones (11) . The resulting library, PST-mpr, was electroporated into DH10B/P3 bacterial cells (Gibco BRL) and plated onto ampicillin/ tetracycline plates.
To screen the library, we used a sib-screen approach (Fig. 3) . We streaked individual colonies onto a plate in a grid format, with the 100 colonies of one plate constituting a pool. Bacteria of each pool were then grown together, and their plasmid DNA was recovered. We transfected the pool DNA into COS-7 cells and assayed for PLAP activity to identify pools containing functional signal peptides. Each positive pool was then divided into 20 subpools, 10 rows and 10 columns, of 10 colonies each, and these subpools were screened for alkaline phosphatase activity. The positive row and column then uniquely identified the signal peptide containing clone in the bacterial grid. Confirmation of that clone's ability to drive PLAP expression to the cell surface was determined by a final round of transfection and assaying. In a preliminary screen of the PST-mpr library, 61 pools were assayed and 17 positives identified (Table 1) . After sequencing the cDNA inserts of the positive clones, we used the National Center for Biotechnology Information (NCBI) BLAST search program to search for sequence homologies with known genes (12) . Nine clones contain MP25, the major mouse prostatic secretory glycoprotein. One isolate encodes a known secreted protein, seminal vesicle protein V. Another clone is a potential homologue to a hypothetical yeast transmembrane protein. We then used a computer program, PSORT, to analyze the encoded amino acid sequences and predict protein localization sites based on protein sorting signals (13) . According to the program, 12 out of the 14 sequences tested contained cleavable signal peptides. Thus, the PST signal peptide trap clearly enriches for signal peptide containing proteins.
Since the PST-mpr library screen demonstrated the efficacy of our signal trap, we decided to screen another library to find molecules that might be related to prostate cancer. Prostate cancer is the most widely diagnosed malignancy in men, and is second only to lung cancer in mortality rates (14) . Nevertheless, very little is known about its molecular basis. Identifying growth regulatory pathways in the prostate, therefore, could be important to understanding the mechanisms responsible for prostatic carcinogenesis, possibly leading to new treatments for the disease.
For our prostate cancer library, PST-LNCaP, we used a subtraction technique designed to amplify representation of genes overexpressed in cancer versus normal cells. To do so, we used two sources for RNA, LNCaP and PrEC cells. LNCaP (American Type Culture Collection) is a human cell line derived from a prostate cancer metastasis in the lymph node. PrEC (Clonetics) is an early passage culture of cells from a normal human prostate. We isolated RNA from each cell culture and then subtracted the PrEC RNA from the LNCaP RNA (15) . The resulting RNA was used to synthesize the cDNA library, PST-LNCaP.
The PST-LNCaP library yielded 19 positives from 13 000 clones screened ( Table 2 ). The secreted, epidermal growth factor family member, amphiregulin, was identified. A known transmembrane protein, the TRAPβ signal sequence receptor subunit, was also found. In addition, potential human homologues of three transmembrane proteins, a rat sodium-dependent neurotransmitter transporter, a rat ATP-binding cassette (ABC) half-transporter, and the yeast p24a endosomal protein, were isolated. According to PSORT, 5 of 11 clones analyzed contain cleavable signal peptides.
Overall, the vast majority (25/27) of the clones, isolated from the two prostate libraries, contain an ATG surrounded by a reasonable Kozak consensus sequence, indicating a likely translational start site (16) . Twenty-five of the 27 encoded proteins also display hydrophobic stretches at their N-terminal ends (Tables 1 and 2) , as determined by the Protean computer program (DNASTAR, Inc.). Interestingly, one clone has neither a hydrophobic N-terminus nor a signal peptide, but does encode the ABC transmembrane transporter. This protein, therefore, demonstrates that our system may be able to recognize membranetargeting signals other than the classical signal peptide found on type I integral membrane proteins.
The PST signal trap system provides a new, easy method to identify secreted and transmembrane proteins. Previously described signal sequence traps require specialized equipment for timeintensive immunostaining and flow cytometry analyses. The PST system uses alkaline phosphatase as a reporter, and therefore requires only a simple addition of substrate to stain cells purple. As demonstrated by our prostate library screens, this signal trap can be used to identify proteins important to intercellular signaling.
